MICHELLE GONZALEZ: Open Payments
NPI 1588373203 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 30 payments from 12 companies in 2025. Trend: 2023 $229 · 2024 $1,869 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $121 |
| TOLMAR, INC. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Merck Sharp & Dohme LLC | 4 | $76 |
| Alexion Pharmaceuticals, Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $42 |
| Antares Pharma, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: JATENZO, ELIQUIS, BREZTRI, STRENSIQ, Wegovy, PREVNAR 20, GARDASIL 9, VERQUVO.
Industry payments across MA — which companies pay providers there.
